GlobeNewswire: Medigus Ltd. Contains the last 10 of 92 releaseshttp://www.globenewswire.com/External?Length=42024-03-19T11:53:47ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2019/01/10/1686072/0/en/Medigus-Announces-CEO-Chris-Rowland-to-Step-Down.html?f=22&fvtc=4&fvtv=20080Medigus Announces CEO Chris Rowland to Step Down2019-01-10T12:30:00Z<![CDATA[OMER, Israel, Jan. 10, 2019 (GLOBE NEWSWIRE) -- (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and an innovator in direct visualization technology, announced today that Mr. Chris Rowland, the company’s chief executive officer, will step down effective as of February 28, 2019. Following such date, Mr. Rowland will continue to work with the company as a consultant to contribute from his experience and understanding of the company’s products to promoting shareholder value through the MUSE™ and ScoutCam™ portfolios.]]>https://www.globenewswire.com/news-release/2018/12/18/1668735/0/en/Medigus-in-Advanced-Negotiations-to-License-its-MUSE-Technology.html?f=22&fvtc=4&fvtv=20080Medigus in Advanced Negotiations to License its MUSE™ Technology2018-12-18T13:48:57Z<![CDATA[OMER, Israel, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that it is in advanced negotiations to grant a license or licenses to its MUSE™ technology Globally and/or in greater China. For this purpose, Medigus commenced advanced talks with relevant multi-national medical device companies and is expected to receive upfront payments that may add up to millions of U.S. dollars should such transactions close.]]>https://www.globenewswire.com/news-release/2018/12/06/1663037/0/en/NASA-Deploys-Medigus-micro-ScoutCam-Miniature-HD-Camera-During-Robotic-Refueling-Mission.html?f=22&fvtc=4&fvtv=20080NASA Deploys Medigus’ micro ScoutCam™ Miniature HD Camera During Robotic Refueling Mission 2018-12-06T13:00:00Z<![CDATA[- Advanced CMOS camera to be launched into space to help broaden satellite servicing capabilities - - Advanced CMOS camera to be launched into space to help broaden satellite servicing capabilities -]]>Visual Inspection Poseable Invertebrate Robot 2 (VIPIR2). Image credit: NASA GoddardVisual Inspection Poseable Invertebrate Robot 2 (VIPIR2). Image credit: NASA Goddardhttps://www.globenewswire.com/news-release/2018/11/28/1658099/0/en/Medigus-Announces-Third-Quarter-2018-Financial-Results.html?f=22&fvtc=4&fvtv=20080Medigus Announces Third Quarter 2018 Financial Results2018-11-28T12:00:00Z<![CDATA[OMER, Israel, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”) (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and direct visualization technology, today announced financial results for the third quarter ended September 30, 2018.]]>https://www.globenewswire.com/news-release/2018/11/20/1654367/0/en/Medigus-Will-Form-a-Separate-Company-for-Its-Novel-Miniature-Video-Cameras-Focused-on-Marketing-for-New-Industries.html?f=22&fvtc=4&fvtv=20080Medigus Will Form a Separate Company for Its Novel Miniature Video Cameras, Focused on Marketing for New Industries2018-11-20T12:00:00Z<![CDATA[The Fully Owned Subsidiary Will Engage in Promoting to New Additional Industries such as Defense, Aviation, Automotive and More]]>https://www.globenewswire.com/news-release/2018/11/15/1652370/0/en/Medigus-Board-of-Directors-Announces-Cost-Reduction-Measures.html?f=22&fvtc=4&fvtv=20080Medigus Board of Directors Announces Cost Reduction Measures2018-11-15T14:00:00Z<![CDATA[OMER, Israel, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”) (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and an innovator in direct visualization technology, issued on November 14, 2018 a letter to the shareholders from the board of directors. In the letter, the board of directors of the Company notified the shareholders that further to the review of the company, its financial condition, products and employees, the board of directors of the company has resolved to take steps to reduce the ordinary course expenses of the company by approximately 20% in order to be better aligned with the company’s business needs. The board of directors believes that such steps are required in order to ensure that the company’s resources are used in the most efficient and optimal way to promote the company’s operations.]]>https://www.globenewswire.com/news-release/2018/09/06/1567310/0/en/Institutional-Shareholder-Services-ISS-Leading-Proxy-Advisor-Recommends-Medigus-Shareholders-Vote-FOR-all-Medigus-Director-Nominees.html?f=22&fvtc=4&fvtv=20080Institutional Shareholder Services (ISS), Leading Proxy Advisor, Recommends Medigus Shareholders Vote “FOR” all Medigus’ Director Nominees2018-09-06T20:05:00Z<![CDATA[-Medigus Implores Stockholders to Protect the Value of Their Investment and Vote “FOR” Medigus’ Director Nominees on the WHITE Proxy Card-]]>https://www.globenewswire.com/news-release/2018/08/30/1563654/0/en/Medigus-Ltd-Announces-Second-Quarter-2018-Financial-Results.html?f=22&fvtc=4&fvtv=20080Medigus Ltd Announces Second Quarter 2018 Financial Results2018-08-30T20:05:00Z<![CDATA[OMER, Israel, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”) (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and direct visualization technology, today announced financial results for the second quarter ended June 30, 2018.]]>https://www.globenewswire.com/news-release/2018/08/01/1545489/0/en/Distribution-Agreement-with-Micro-Tech-Endoscopy-USA-Represents-Significant-Milestone-for-Medigus-to-Enter-U-S-Market.html?f=22&fvtc=4&fvtv=20080Distribution Agreement with Micro-Tech Endoscopy USA Represents Significant Milestone for Medigus to Enter U.S. Market2018-08-01T13:00:00Z<![CDATA[OMER, Israel, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and an innovator in direct visualization technology, today announced an exclusive distribution agreement for its Medigus Ultrasonic Surgical Endostapler (MUSE™) system in the U.S. with Micro-Tech Endoscopy USA, Inc., a leading global manufacturer of GI endoscopy disposables and non-vascular stents, and wholly – owned subsidiary of Micro-Tech (Nanjing) Co. Ltd. The new commercialization agreement takes effect immediately for an initial term of three years with annual increases in minimum purchases for the first seven years. Medigus also has an exclusive distribution agreement with Micro-Tech Europe for the MUSE™ system in Germany.]]>https://www.globenewswire.com/news-release/2018/07/23/1540853/0/en/Medigus-Announces-Closing-of-10-Million-Public-Offering.html?f=22&fvtc=4&fvtv=20080Medigus Announces Closing of $10 Million Public Offering 2018-07-23T20:05:00Z<![CDATA[OMER, Israel, July 23, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”)(NASDAQ:MDGS) (TASE:MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced the closing of its previously announced underwritten public offering of 2,837,674 units at a price of $3.50 per unit. Each unit consists of (i) one American Depositary Share, or ADS (or ADS equivalents), and (ii) one Series C warrant to purchase one ADS. The ADSs (or ADS equivalents) and the accompanying Series C warrants included in the units were purchased together in the offering, but were issued separately and were immediately separable upon issuance. The Company received gross proceeds of approximately $10 million.]]>